Literature DB >> 24689185

Efficacy of a live attenuated Escherichia coli O78:K80 vaccine in chickens and turkeys.

R M La Ragione, M J Woodward, M Kumar, J Rodenberg, H Fan, A D Wales, K Karaca.   

Abstract

A candidate live vaccine for avian pathogenic Escherichia coli (APEC) was constructed from a virulent field APEC 078 strain by mutation of the aroA gene. The mutant was highly similar to the parent wild-type strain in respect of colony morphology, motility, growth in suspension, hemagglutination, Congo Red binding, HEp-2 cell adhesion, and the elaboration of surface antigens type 1 fimbriae and flagella, although production of curli fimbriae was reduced marginally. The mutant proved avirulent when inoculated into 1-day-old chicks by spray application and when presented again in the drinking water at 7 days of age. Chickens and turkeys vaccinated with an 078 aroA mutant were protected against a challenge at 6 wk of age by virulent APEC strains.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24689185     DOI: 10.1637/10326-081512-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  9 in total

1.  Evaluation of commercially available aroA delated gene E. coli O78 vaccine in commercial broiler chickens under Middle East simulating field conditions.

Authors:  Hussein M Galal; M I Abdrabou; Ahmed H I Faraag; C K Mah; Azza M Tawfek
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

2.  Effects of the monoacylglycerol lipase inhibitor JZL184 on chickens infected with avian pathogenic Escherichia coli O78: A preliminary pharmacokinetic and infection study.

Authors:  Cherry P Ho; Abdolsamad Borazjani; Matthew K Ross; Chinling Wang
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

3.  Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys.

Authors:  Jean-Rémy Sadeyen; Zhiguang Wu; Holly Davies; Pauline M van Diemen; Anita Milicic; Roberto M La Ragione; Pete Kaiser; Mark P Stevens; Francis Dziva
Journal:  Vet Res       Date:  2015-01-23       Impact factor: 3.683

4.  Efficacy of an avian colibacillosis live vaccine for layer breeder in Japan.

Authors:  Yusuke Uotani; Rie Kitahara; Takahiko Imai; Nobuyuki Tsutsumi; Chihiro Sasakawa; Shinya Nagai; Tetsuji Nagano
Journal:  J Vet Med Sci       Date:  2017-06-11       Impact factor: 1.267

5.  Antimicrobial activity of carbon monoxide-releasing molecule [Mn(CO)3(tpa-κ3N)]Br versus multidrug-resistant isolates of Avian Pathogenic Escherichia coli and its synergy with colistin.

Authors:  Jonathan Betts; Christopher Nagel; Ulrich Schatzschneider; Robert Poole; Robert M La Ragione
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

6.  Recent approaches for control of E. coli and respiratory complex in Middle East.

Authors:  Hussein M Galal; Azza M Tawfek; Mohamed I Abdrabou; Ashgan Mohamed Hessain; Jwaher Haji Alhaaji; Saleh A Kabli; Ayman Elbehiry; Waleed K Alwarhi; Ihab M Moussa
Journal:  Saudi J Biol Sci       Date:  2018-04-03       Impact factor: 4.219

Review 7.  Avian Pathogenic Escherichia coli (APEC): An Overview of Virulence and Pathogenesis Factors, Zoonotic Potential, and Control Strategies.

Authors:  Dipak Kathayat; Dhanashree Lokesh; Sochina Ranjit; Gireesh Rajashekara
Journal:  Pathogens       Date:  2021-04-12

Review 8.  Is the Concept of Avian Pathogenic Escherichia coli as a Single Pathotype Fundamentally Flawed?

Authors:  Charlotte Collingwood; Kirsty Kemmett; Nicola Williams; Paul Wigley
Journal:  Front Vet Sci       Date:  2014-10-14

9.  Characterization of Spleen Transcriptome and Immunity Against Avian Colibacillosis After Immunization With Recombinant Attenuated Salmonella Vaccine Strains.

Authors:  Zachary R Stromberg; Angelica Van Goor; Graham A J Redweik; Melha Mellata
Journal:  Front Vet Sci       Date:  2018-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.